drugset / Trial / NCT01043536

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

NCT01043536 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The main goal of this study is to evaluate and to determine the dose of a highly accurate irradiation (allowing to increase the dose delivered while restricting the risk of complication) in association with temozolomide.

Timeline

Start
2009-09
Primary completion
2012-01
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule 200 mg/m2 —

Indications